
Duobind develops molecular glues that enable targeted protein–protein interactions. It designs these molecules with computational methods, structural biology, and machine learning. The platform engineers glue candidates systematically rather than finding them by chance. Category: B2B biotech platform for pharma research. The approach targets diseases traditional drugs can't reach, aiming to scale through industry partnerships.

Duobind develops molecular glues that enable targeted protein–protein interactions. It designs these molecules with computational methods, structural biology, and machine learning. The platform engineers glue candidates systematically rather than finding them by chance. Category: B2B biotech platform for pharma research. The approach targets diseases traditional drugs can't reach, aiming to scale through industry partnerships.